PONZ DE LEON, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 39.791
AS - Asia 17.736
EU - Europa 15.898
SA - Sud America 2.521
AF - Africa 322
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 18
Totale 76.314
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 39.405
GB - Regno Unito 7.278
SG - Singapore 6.060
CN - Cina 5.048
HK - Hong Kong 2.041
BR - Brasile 1.964
VN - Vietnam 1.672
SE - Svezia 1.553
DE - Germania 1.434
IT - Italia 1.175
UA - Ucraina 1.093
FI - Finlandia 981
TR - Turchia 875
RU - Federazione Russa 663
FR - Francia 620
KR - Corea 485
BG - Bulgaria 388
IN - India 345
AR - Argentina 202
BD - Bangladesh 194
CA - Canada 171
ID - Indonesia 150
IQ - Iraq 143
MX - Messico 137
NL - Olanda 121
JP - Giappone 103
EC - Ecuador 99
ZA - Sudafrica 96
IE - Irlanda 86
BE - Belgio 83
PK - Pakistan 83
ES - Italia 78
AE - Emirati Arabi Uniti 71
CO - Colombia 65
PL - Polonia 63
CL - Cile 58
VE - Venezuela 58
MY - Malesia 48
UZ - Uzbekistan 45
SA - Arabia Saudita 43
AT - Austria 41
MA - Marocco 39
PH - Filippine 38
NP - Nepal 36
LT - Lituania 33
RO - Romania 33
TN - Tunisia 33
EG - Egitto 32
KE - Kenya 30
DZ - Algeria 29
JO - Giordania 28
TH - Thailandia 28
AZ - Azerbaigian 27
CZ - Repubblica Ceca 26
PY - Paraguay 26
TW - Taiwan 23
AU - Australia 21
IL - Israele 20
PE - Perù 20
OM - Oman 16
CH - Svizzera 15
IR - Iran 15
KZ - Kazakistan 15
PT - Portogallo 14
DO - Repubblica Dominicana 13
AL - Albania 12
BO - Bolivia 12
BY - Bielorussia 12
DK - Danimarca 12
UY - Uruguay 12
CR - Costa Rica 11
ET - Etiopia 11
EU - Europa 11
JM - Giamaica 11
SY - Repubblica araba siriana 11
GE - Georgia 10
GR - Grecia 9
LB - Libano 9
MD - Moldavia 9
PS - Palestinian Territory 9
RS - Serbia 9
PA - Panama 8
HR - Croazia 7
KG - Kirghizistan 7
KW - Kuwait 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
PR - Porto Rico 7
SN - Senegal 7
BA - Bosnia-Erzegovina 6
HU - Ungheria 6
LK - Sri Lanka 6
NG - Nigeria 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BH - Bahrain 5
BZ - Belize 5
EE - Estonia 5
GA - Gabon 5
HN - Honduras 5
MK - Macedonia 5
Totale 76.214
Salva come PNG Salva come JPEG
Città #
Southend 5.521
Singapore 4.074
Fairfield 3.408
Santa Clara 3.203
Ashburn 3.018
Woodbridge 2.650
Jacksonville 2.219
Houston 2.207
Hong Kong 2.021
Chandler 1.835
Hefei 1.744
Dearborn 1.426
Ann Arbor 1.336
Wilmington 1.314
Seattle 1.286
Chicago 1.264
Cambridge 1.115
San Jose 1.013
Beijing 902
Nyköping 895
Los Angeles 877
London 861
Helsinki 579
The Dalles 543
Salt Lake City 542
Ho Chi Minh City 513
Princeton 486
Izmir 463
Seoul 443
Hanoi 406
Sofia 380
Eugene 367
Modena 366
San Diego 355
Lauterbourg 299
Des Moines 289
Council Bluffs 283
New York 261
Elk Grove Village 253
Tampa 238
Moscow 224
Buffalo 213
Dallas 207
Shanghai 190
São Paulo 158
Sterling 138
Frankfurt am Main 135
Lancaster 125
Milan 124
Columbus 120
Bremen 114
Munich 113
Grafing 101
Falls Church 99
Miami 97
Da Nang 88
Orem 87
Tokyo 82
Jakarta 79
Guangzhou 72
Boardman 71
Phoenix 69
Dulles 66
Detroit 65
Atlanta 62
Brussels 62
Haiphong 62
Rio de Janeiro 62
Dublin 61
Norwalk 61
Falkenstein 58
Baghdad 56
Fremont 56
Kunming 56
Chennai 55
Nanjing 54
Mexico City 53
Belo Horizonte 50
Brooklyn 47
Kent 47
Quito 46
Rochester 45
Kansas City 44
Cardiff 42
Dhaka 40
Pittsburgh 40
Tashkent 40
Turku 40
Denver 39
Jinan 38
Montreal 38
Philadelphia 37
Curitiba 36
Nuremberg 36
Porto Alegre 36
Brasília 35
Chiswick 34
Toronto 34
Ottawa 33
Changsha 32
Totale 55.759
Salva come PNG Salva come JPEG
Nome #
Estimates of cancer burden in Italy 696
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 458
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 443
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 436
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 434
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 433
Differentiated Thyroid Carcinoma (DTC) in a Young Woman with Peutz-Jeghers Syndrome: are these Two Conditions Associated? 420
Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. 419
Lymph node micrometastasis and survival of patients with Stage i (Dukes' A) colorectal carcinoma 414
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 406
A two-locus model for hereditary non-polyposis colorectal cancer in Modena, Italy 404
Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry 399
Attenuated polyposis of the large bowel: a morphologic and molecular approach 397
Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life. 396
Cyclooxygenase-2 and Hypoxia-Inducible Factor-1 alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis 393
K-ras and p53 mutations in human colorectal aberrant crypt foci 388
Morphological and quantitative analysis of BCL6 expression in human colorectal carcinogenesis. 388
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 383
Microsatellite instability in multiple colorectal tumors 380
A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability. 379
The influence of age on colonic epithelial cell proliferation 368
Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel 366
IDENTIFICATION OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER IN THE GENERAL-POPULATION - THE 6-YEAR EXPERIENCE OF A POPULATION-BASED REGISTRY 366
Aetiology of colorectal cancer and relevance of monogenic inheritance. 365
Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms. 364
The cause of colorectal cancer 362
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 362
Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome 360
Aberrant crypt foci in patients with colorectal cancer 358
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 357
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 354
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 353
An unusual case of familial adenomatous polyposis with very early symptom occurrence 351
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 349
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors 341
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 336
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 334
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 334
Survival analysis in families affected by hereditary non-polyposis colorectal cancer 330
Histology of aberrant crypt foci in the human colon 329
Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis. 327
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 326
Clinical features and colorectal cancer survival: an attempt to explain differences between two different Italian regions. 326
Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages 323
Small bowel carcinoma in hereditary nonpolyposis colorectal cancer 318
Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis 316
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 313
PLZF expression during colorectal cancer development and in normal colorectal mucosa according to body size, as marker of colorectal cancer risk. 312
Problems in the identification of hereditary nonpolyposis colorectal cancer in two families with late development of full-blown clinical spectrum 311
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study 311
First observation of microadenomas in the ileal mucosa of patients with familial adenomatous polyposis and colectomies 311
Carcinoma papillare e Sindrome di Peutz-Jeghers: una rara associazione 311
Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature 309
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 306
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 303
Clinical features of colorectal cancer patients in advanced age: a population-based approach 303
Decrease in plasma tryptophan after a tryptophan-free amino acid solution. A comparison between cirrhotic and control subjects 299
Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer 298
Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer. 296
Cholesterol esterase activity of human intestinal mucosa 294
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 292
Microsatellite instability and colorectal cancer prognosis. 291
Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: A population-based study 290
Investigation of APC mutations in a Turkish familial adenomatous polyposis family by heterodublex analysis 289
Cancer prevalence in Italian cancer registry areas: The ITAPREVAL study 286
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis 285
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 284
Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome. 284
Infliximab-related hepatitis: discussion of a case and review of the literature. 282
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 282
Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree 279
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary 279
Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. 279
Alteration of drug metabolism during cholestasis in man 277
Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal-cancer registries 274
Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes 271
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 270
A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability. 269
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 269
The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and women 267
A case of pneumatosis cystoides intestinalis mimicking familial adenomatous polyposis 265
Colorectal carcinoma in different age groups: A population based investigation 264
I tumori in Italia. Rapporto 2011: La sopravvivenza dei pazienti oncologici in Italia 264
Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: a population-based study 263
Antioxidant vitamins and colorectal adenoma 263
Analysis of mismatch repair gene mutations in Turkish HNPCC patients. 262
Peutz-Jeghers syndrome: a systematic review and recommendations for management 262
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 262
Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study 262
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 261
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 259
Effects of acute changes of bile acid pool composition on biliary lipid secretion 258
Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. 258
Preventive war and chemoprevention of cancer 257
In response. Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability. 256
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 255
Biological characterization of mucinous carcinoma of the colon and rectum 254
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 253
Incidence trend of malignant polyps through the data of a specialized colorectal cancer registry: clinical features and effect of screening. 253
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: A retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database 251
Totale 32.499
Salva come PNG Salva come JPEG
Categoria #
all - tutte 294.565
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 294.565
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.389 0 0 0 0 0 0 0 0 0 755 352 282
2021/20225.836 154 907 466 488 134 285 358 273 633 392 1.072 674
2022/20235.088 686 528 321 499 628 951 66 451 608 35 189 126
2023/20243.078 120 211 186 190 799 257 298 435 81 47 98 356
2024/202511.798 445 117 146 870 2.404 1.693 767 654 1.310 708 1.238 1.446
2025/202623.668 1.449 1.011 2.235 3.595 5.892 1.675 2.785 1.323 2.027 1.676 0 0
Totale 76.580